InsideArbitrage Event Driven Monitor – April 11, 2024
Merger Arbitrage X: On April 9, 2024, Nippon Steel filed with the European Commission for its acquisition of U.S. Steel (X). The European antitrust regulator has set the provisional deadline as May 17, 2024. ALPN: The acquisition of Alpine Immune Sciences, Inc. (ALPN) by Vertex Pharmaceuticals Inc. (VRTX) for $4.9 billion. As per the terms of the merger agreement, Vertex will acquire Alpine for $65 per share in cash. ANSS: On April 10, 2024, Ansys (ANSS) filed a definitive proxy statement. The special meeting of its shareholders will be held on June 7, 2024. Their merger with Synopsys (SNPS) is expected to close expected to close in the first half of 2025. FUSN: On April 10, 2024, Fusion Pharmaceuticals (FUSN) and AstraZeneca (AZN) filed their preliminary proxy statement. On March 22, 2024, the companies submitted to the DOJ and FTC the notifications required under the HSR Act. The statutory waiting period expires on April 22, 2024. TGAN: On April 10, 2024, Shareholders of Transphorm (TGAN) approved the company’s merger with Renesas Electronics at a special meeting of shareholders held on April 9, 2024. You can check out new deals, all deal updates, and spreads on active deals in our Merger Arbitrage Tool for premium members here. Deal in...
Only plus or premium subscribers can access this post. Subscribe today.
